Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review

Prostate cancer (PCa) is the second leading cause of cancer among men, and its diagnosis and adequate staging are fundamental. Among the biomarkers identified in recent years for PCa management, prostate-specific-membrane-antigen (PSMA), physiologically expressed at a low level on healthy prostate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Frigerio, Barbara, Luison, Elena, Desideri, Alessandro, Iacovelli, Federico, Camisaschi, Chiara, Seregni, Ettore C., Canevari, Silvana, Figini, Mariangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698710/
https://www.ncbi.nlm.nih.gov/pubmed/34944686
http://dx.doi.org/10.3390/biomedicines9121870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698710/
https://www.ncbi.nlm.nih.gov/pubmed/34944686
http://dx.doi.org/10.3390/biomedicines9121870

Ejemplares similares